ATE357239T1 - Entzündungshemmendes medikament auf laminarinsulfat-basis - Google Patents

Entzündungshemmendes medikament auf laminarinsulfat-basis

Info

Publication number
ATE357239T1
ATE357239T1 AT01992577T AT01992577T ATE357239T1 AT E357239 T1 ATE357239 T1 AT E357239T1 AT 01992577 T AT01992577 T AT 01992577T AT 01992577 T AT01992577 T AT 01992577T AT E357239 T1 ATE357239 T1 AT E357239T1
Authority
AT
Austria
Prior art keywords
sulphate
laminarine
inflammatory drug
based anti
degree
Prior art date
Application number
AT01992577T
Other languages
English (en)
Inventor
Jean-Claude Yvin
Susanne Alban
Gerhard Franz
Original Assignee
Goemar Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goemar Lab Sa filed Critical Goemar Lab Sa
Application granted granted Critical
Publication of ATE357239T1 publication Critical patent/ATE357239T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01992577T 2000-11-03 2001-11-02 Entzündungshemmendes medikament auf laminarinsulfat-basis ATE357239T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0014118A FR2816213B1 (fr) 2000-11-03 2000-11-03 Medicament anti-inflammatoire et cicatrisant

Publications (1)

Publication Number Publication Date
ATE357239T1 true ATE357239T1 (de) 2007-04-15

Family

ID=8856038

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01992577T ATE357239T1 (de) 2000-11-03 2001-11-02 Entzündungshemmendes medikament auf laminarinsulfat-basis

Country Status (10)

Country Link
US (1) US7008931B2 (de)
EP (1) EP1337261B1 (de)
AT (1) ATE357239T1 (de)
AU (1) AU2002223731A1 (de)
CA (1) CA2427744A1 (de)
DE (1) DE60127440T2 (de)
ES (1) ES2284722T3 (de)
FR (1) FR2816213B1 (de)
PT (1) PT1337261E (de)
WO (1) WO2002036132A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660722B2 (en) * 2001-11-30 2003-12-09 Laboratoires Goemar S.A. Therapeutical treatments
ES2251289B1 (es) * 2004-02-27 2007-07-01 Bioiberica, S.A. Nuevo uso terapeutico de un grupo de polisacaridos sulfatados.
FR2885812B1 (fr) * 2005-05-18 2007-07-27 Goemar Lab Sa Medicament a base de laminarine ou d'oligolaminarines pour le traitement de la septicemie et du choc septique
FR2885810B1 (fr) * 2005-05-18 2007-08-10 Goemar Lab Sa Nouveau medicament anti-steatohepatique a base de laminarine ou d'oligolaminarines
FR2885809B1 (fr) * 2005-05-18 2007-08-10 Goemar Lab Sa Medicament anti-steatohepatique a base de laminarine ou d'oligominarines
FR2899815B1 (fr) * 2006-04-14 2008-07-11 Goemar Lab Sa Nouveaux medicaments pour les traitements contre les retrovirus
EP3295795A1 (de) 2013-03-20 2018-03-21 Bioatlantis Limited Verwendung einer nichtnematiziden zusammensetzung
WO2023002252A1 (en) 2021-07-21 2023-01-26 Bioatlantis Limited Composition comprising beta-glucans and alpha-fucans for improving gut health and animal performance and methods of making the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB911484A (en) * 1959-12-24 1962-11-28 Boots Pure Drug Co Ltd The preparation of anti-lipaemic agents
JPS5224555B2 (de) * 1973-04-18 1977-07-01
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
IL108951A0 (en) * 1994-03-13 1994-06-24 Hadasit Med Res Service Pharmaceutical compositions containing polysulfated polysaccharides
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe

Also Published As

Publication number Publication date
EP1337261B1 (de) 2007-03-21
FR2816213A1 (fr) 2002-05-10
DE60127440T2 (de) 2007-11-29
US7008931B2 (en) 2006-03-07
CA2427744A1 (fr) 2002-05-10
WO2002036132A1 (fr) 2002-05-10
PT1337261E (pt) 2007-06-22
EP1337261A1 (de) 2003-08-27
FR2816213B1 (fr) 2005-04-22
DE60127440D1 (de) 2007-05-03
ES2284722T3 (es) 2007-11-16
US20040127457A1 (en) 2004-07-01
AU2002223731A1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
BR0316438A (pt) Uso de eritropoietina em doenças cardìacas
IS6491A (is) Pteridínefnasambönd til meðhöndlunar á sóríasis
DOP2002000429A (es) Imidazotriazinas
EE04938B1 (et) Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena
BR9607171A (pt) Anticorpos monoclonais anti-cd6 e usos dos mesmos
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
ES2135046T3 (es) 2-isoxazolinas e isoxazoles 3,5-disustituidos y 3,4,5-trisustituidos, procedimiento para su preparacion y su empleo como medicamentos.
ATE357239T1 (de) Entzündungshemmendes medikament auf laminarinsulfat-basis
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
BG102623A (bg) Нови производни на бензоилгуанидина, методи за тяхното получаване и приложението им за производството на ле- карствени средства
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
SE9400447D0 (sv) New compounds
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
BR9807437A (pt) Anticorpos monoclonais gama-1 e gama-3 anti-humanos cd23 e sua utilização como terapêuticos
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
DE50203154D1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
HUP0402624A2 (hu) Vírusgátlás n-dokozanollal
BR9707772A (pt) Composições farmacêuticas compreendendo alfa-interferon humano natural
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties